This trial will explore the link between cannabis use disorder, brain activity, and cognitive function to see how they affect each other.
- Cannabis Use Disorder
1 Primary · 2 Secondary · Reporting Duration: Baseline and Day 28
Awards & Highlights
2 Treatment Groups
1 of 2
Cannabis use disorder
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: Healthy control · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18 - 55 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Frequently Asked Questions
Am I a permissible participant for this clinical research?
"In order to be admitted into this medical trial, the subject must suffer from a cannabis use disorder and fall within the 18-55 years old age bracket. Approximately 60 individuals will receive admittance." - Anonymous Online Contributor
Is the current research open to those aged eighteen and over?
"Qualified participants must range between 18 and 55. Meanwhile, 15 trials are available for individuals under the age of majority while 49 offer treatment to those 65 or older." - Anonymous Online Contributor
Does this medical trial have any openings for participants?
"According to information hosted on clinicaltrials.gov, this trial has ceased recruiting patients since its last edit of December 22nd 2022 and is not currently seeking participants. Despite that, there are still 121 other medical studies actively welcoming volunteers for engagement in their trials." - Anonymous Online Contributor